ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1985

Validity and Reliability of Four Parent/Patient Reported Outcome Measures for Juvenile Idiopathic Arthritis

Chiara Trincianti1, E. H. Pieter Van Dijkhuizen2, Serena Calandra3, Helga Sanner4, Tamas Constantin5, Troels Herlin6, Marco Cattalini7, Flavio Sztajnbok8, Despoina Maritsi9, Nicolino Ruperto10, Angelo Ravelli11 and Alessandro Consolaro11, 1Istituto Giannina Gaslini, Genova, Liguria, Italy, 2Wilhelmina Children’s Hospital, Utrecht, Netherlands, 3IRCCS Istituto Giannina Gaslini, Genoa, Liguria, Italy, 4Oslo University Hospital, Oslo, Norway, 5Semmelweis University, Budapest, Hungary, 6Aarhus University Hospital, Aarhus, Denmark, 7Università di Brescia, Brescia, Italy, 8Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 9National and Kapodistrian University of Athens, Athens, Greece, 10Istituto Giannina Gaslini, Genova, Italy, 11Università degli Studi di Genova, Genoa, Italy

Meeting: ACR Convergence 2020

Keywords: Juvenile idiopathic arthritis, Patient reported outcomes, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Pediatric Rheumatology – Clinical II: Outcomes & Care Delivery (1983–1987)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: In the last years, the interest in the assessment of parent- and child-reported outcomes (PCROs) in paediatric rheumatic diseases is gaining increasing importance. These measures reflect the parent and child perception of the disease course and effectiveness of therapeutic interventions and may facilitate concordance with physician’s choices, improve treatment adherence, and participation in a shared decision -making strategy. Moreover, the availability of reliable PCROs could be crucial for remote monitoring of patients when in person clinical evaluation may be difficult or even not possible. Aim of this work is to provide further evidence of validity and reliability for four PCRO measures included in the OMERACT JIA core domain set: the evaluation of the child’s pain and of the child’s level of disease activity, the assessment of the morning stiffness (MS) duration, and an active joint count for parent/patient proxy or self-assessment.

Methods: Pain and disease activity were rated on a 21-numbered circle scale ranging from 0 (best result) to 10 (worst result). MS was measured with a 5-point Likert scale. The proxy- and self-assessment of active joints was obtained by rating the presence of pain or swelling in the following joints or joint groups: cervical spine, lumbo-sacral spine, shoulders, elbows, wrists, small hand joints, hips, knees, ankles, and small foot joints. To each joint or joint group, one point was given in case of monolateral involvement, two points in case of bilateral involvement. Patients were included in a multinational dataset of patients enrolled in the Epidemiology Treatment and Outcome of Childhood Arthritis study. Criterion validity was assessed by examining the correlation of the four tested measures with physician centered measures, ESR, and composite disease activity scores. Correlations of the measure with the cJADAS10 were also computed after grouping patients by ILAR category, by geographic area, and by education level. Reliability was assessed in a subset of subjects with Spearman correlations and intraclass correlation coefficients (ICC), comparing two visits 7-14 days apart.

Results: A total of 8,848 parents and 6,204 patients had all the evaluations available. Correlations of tested measures were moderate (0.4–0-7) with physician centered measures and poor (< 0.4) with ESR. The level of correlation of the tested parent measures with the cJADAS10 remained stable after grouping patients by ILAR category. In the same analysis with patients grouped in eight geographic areas, correlation levels were similar, although, on average, they were higher in Latin America and slightly lower in North America. The levels of correlation with the cJADAS10 were similar in subjects in which the level of education of the parent filling the questionnaire was elementary or lower, high school, or degree, respectively. In 442 parents and 344 children, correlations between first and second assessment was > 0.7 for all measures; ICC ranged between 0.79 and 0.87 for parents and 0.81 and 0.88 for children.

Conclusion: The four tested PCROs showed good criterion validity and excellent reliability. These tools can be considered for remote patient assessment, when in person evaluation might not be possible.


Disclosure: C. Trincianti, None; E. Van Dijkhuizen, None; S. Calandra, None; H. Sanner, None; T. Constantin, None; T. Herlin, None; M. Cattalini, None; F. Sztajnbok, None; D. Maritsi, None; N. Ruperto, Ablynx, 5, 8, Astrazeneca-Medimmune, 5, 8, Biogen, 5, 8, Boehringer, 5, 8, Bristol Myers Squibb, 2, 5, 8, 9, Eli Lilly, 2, 5, 8, 9, EMD Serono, 5, 8, GlaxoSmithKline, 2, 5, 8, 9, F Hoffmann-La Roche, 2, 5, 8, 9, Janssen, 2, 5, 8, 9, Merck, 5, 8, Novartis, 2, 5, 8, 9, Pfizer, 2, 5, 8, 9, R-Pharma, 5, 8, Sanofi, 5, 8, Servier, 5, 8, Sinergie, 5, 8, Sobi, 2, 5, 8, 9, AbbVie, 5, 8, Takeda, 5, 8; A. Ravelli, AbbVie, BMS, Pfizer, Hoffman LaRoche, Novartis, Centocor, "Francesco Angelini" and Reckitt Benckiser., 1, 2; A. Consolaro, None.

To cite this abstract in AMA style:

Trincianti C, Van Dijkhuizen E, Calandra S, Sanner H, Constantin T, Herlin T, Cattalini M, Sztajnbok F, Maritsi D, Ruperto N, Ravelli A, Consolaro A. Validity and Reliability of Four Parent/Patient Reported Outcome Measures for Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/validity-and-reliability-of-four-parent-patient-reported-outcome-measures-for-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validity-and-reliability-of-four-parent-patient-reported-outcome-measures-for-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology